Hikma Pharmaceutical | HIK - Stammkapital

Aktienkurs
1,385.00
Täglich Wechseln
-17.50 -1.25%
Monatlich
8.80%
Jährlich
-27.07%
Q2 Prognose
1,361.73




Stammkapital Veränderung Datum
Almirall EUR 214.79M 0 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Autolus Therapeutics Ltd USD 266.14M 1.88K 2025-09
Bayer EUR 982.42M 0 2025-12
Fresenius EUR 563.24M 0 2025-09
Galapagos EUR 65.9M 0 2025-12
Genmab DKK 61.62M 52K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2025-12
Orion EUR 140.87M 173K 2026-03
Recordati EUR 205.83M 270K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12